Radiotherapy: Clinical Trials

24 trials of Radiotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 unknown, 9 completed, 2 recruiting, 2 withdrawn. 24 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 424Unknown 10, Completed 9, Recruiting 2, Withdrawn 2, Not yet recruiting 1

Follow Radiotherapy: new trials by email Literature Review of Radiotherapy trials Research Report on Radiotherapy

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Next Generation STAR-TREC (NG-ST) - Organ Preservation in Early Rectal Cancer
Capecitabine + Radiotherapy, Total Mesorectal Excision (TME) - Rectal Cancer
Phase 4Not yet recruitingVastra Gotaland Region902026-03-122026-03-19
Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis
Corticosteroid injection (CSI), Low-dose radiotherapy (LDRT) - Osteoarthritis Hand, Osteoarthritis Wrist
Phase 4RecruitingMayo Clinic1652025-12-192026-04-24
Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
Deferred Cytoreductive Nephrectomy + medical treatment, Radiotherapy + medical treatment, Medical therapy - Renal Cell Cancer, Kidney Neoplasm
Phase 4RecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS4092025-06-152025-07-03
Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES)
Tislelizumab + cisplatin + paclitaxel, Tislelizumab + radiotherapy - Esophageal Squamous Cell Carcinoma
Phase 4UnknownFirst Affiliated Hospital Xi'an Jiaotong University322022-10-102023-06-29
Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis
Donafenib - HCC, Chemotherapy Effect
Phase 4UnknownAnhui Provincial Hospital302021-09-302021-09-21
Total Neoadjuvant Therapy in Rectal Cancer Treatment
Concurrent Chemoradiotherapy, TME, consolidation chemotherapy - Rectal Cancer
Phase 4UnknownState Scientific Centre of Coloproctology, Russian Federation2802020-10-302021-02-15
Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)
Endocrine Therapy and Radiotherapy - Early-stage Breast Cancer
Phase 4CompletedOttawa Hospital Research Institute2622019-09-172022-09-30
Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer
Zoledronic acid, Radiotherapy - Non-small Cell Lung Cancer, Bone Metastasis
Phase 4UnknownDaping Hospital and the Research Institute of Surgery of the Third Military Medical University2802019-06-012019-01-16
Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or Hypopharynx
Radiation Therapy, Chemotherapy - Advanced Squamous Cell Carcinoma
Phase 4WithdrawnUniversity of Florida2019-02-042019-05-13
Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer
Resection, Radiotherapy, Chemotherapy - Oropharyngeal Cancer
Phase 4UnknownUniversitätsklinikum Hamburg-Eppendorf2802018-01-052023-05-17
Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis
lidocaine/prilocaine (5%) application, 2940-nm Er:YAG AFL pretreatment, MAL application - Actinic Keratosis
Phase 4CompletedDong-A University472017-02-012018-11-06
The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor
Radiotherapy, Elective neck dissection - Oral Cancer
Phase 4UnknownShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University2702016-07-012017-01-11
Treatment of Natural Killer/T Cell Lymphoma-I/II
DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase), VIPD(cisplatin,Etoposide,Ifosfamide, dexamethasone,Mesna), gemcitabine,pegaspargase,cisplatin,dexamethasone - Nasal and Nasal-type NK/T-cell Lymphoma
Phase 4UnknownMingzhi Zhang2002011-01-012015-07-17
Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)
radiotherapy combined with EP, radiotherapy / EP combined with recombinant human endostatin - Non-small Cell Lung Cancer
Phase 4UnknownSimcere Pharmaceutical Co., Ltd1702010-10-012010-09-29
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
chemotherapy plus p53, chemotherapy, radiotherapy - Neoplasms
Phase 4UnknownShenzhen SiBiono GeneTech Co.,Ltd12002009-05-012012-04-09
Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
Temozolomide, Radiotherapy - Glioblastoma
Phase 4CompletedMerck Sharp & Dohme LLC992008-06-242017-06-14
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Brachytherapy, Intracavitary accelerated partial breast irradiation - Breast Cancer, Carcinoma
Phase 4CompletedXoft, Inc.632008-05-012016-05-17
Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)
Concurrent chemoradiotherapy (paclitaxel plus cisplatin plus radiotherapy) - Non-small-cell Lung Cancer
Phase 4CompletedTaipei Veterans General Hospital, Taiwan62008-04-012011-09-15
Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX
Casodex 150mg, Radiotherapy, Haematology - Prostate Cancer
Phase 4CompletedAstraZeneca1252003-06-012008-01-25
Epoetin Beta in Treating Anemia in Patients With Cervical Cancer
epoetin beta, cisplatin, brachytherapy - Anemia, Cervical Cancer
Phase 4CompletedAGO Study Group4502002-07-012013-05-30

Showing 20 of 24. Sign in to see all of them.

Conditions studied

Carcinoma, Non-Small-Cell Lung (3)  ·  Anemia (2)  ·  Breast Neoplasms (2)  ·  Hodgkin Disease (2)  ·  Rectal Neoplasms (2)  ·  Blast Crisis (1)  ·  Burkitt Lymphoma (1)  ·  Carcinoma (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Carcinoma, Renal Cell (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  Glioblastoma (1)  ·  Graft vs Host Disease (1)  ·  Keloid (1)

Sponsors

AGO Study Group (1)  ·  Anhui Provincial Hospital (1)  ·  AstraZeneca (1)  ·  Charite University, Berlin, Germany (1)  ·  Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (1)  ·  Dong-A University (1)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Mayo Clinic (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Mingzhi Zhang (1)  ·  Ottawa Hospital Research Institute (1)  ·  Queen Mary University of London (1)  ·  Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1)  ·  Shenzhen SiBiono GeneTech Co.,Ltd (1)

Countries

China (5)  ·  Germany (4)  ·  United States (4)  ·  Canada (1)  ·  Italy (1)  ·  Russia (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Barry R. Meisenberg, MD (1)  ·  Chia-Jung Busch, PD Dr. (1)  ·  Eckhard Thiel, MD (1)  ·  Evgeny Rybakov, Dr.Med.Sc (1)  ·  Ge Wang, Doctor (1)  ·  Haluk Ozen, Prof (1)  ·  Heinz Koelbl, MD (1)  ·  Jean Marc Bourque, MD (1)  ·  Junke Fu (1)  ·  Ki-hoon Song, MD (1)  ·  Mingzhi Zhang, Pro,Dr (1)  ·  Peter Beitsch, MD (1)  ·  Rakesh Patel, MD (1)  ·  Ralph Naumann, MD (1)

Results publications

PMID 19484483, PMID 20970380, PMID 23053582, PMID 26481741, PMID 32727416, PMID 33034052, PMID 37650478, PMID 42433301

NIH funding

2025 (1)